ONCOLYTIC VIRUS PEER REVIEW JOURNALS
Oncolytic viruses (OVs) infect and kill malignant cells, leaving surrounding healthy cells unharmed. Initial interest within the use of viruses to treat cancer dates back to observations made within the early 1900s of tumor regression within the context of natural virus infection . Improved tumor selectivity and inherent self-replication kinetics leave targeted therapy and localized therapeutic amplification, reducing the danger of systemic toxicity.
Oncolytic viruses supported several different vectors including adenovirus, herpes simplex virus (HSV), vaccinia virus, Newcastle disease virus, measles virus, and reovirus are shown to be tumor-specific, relatively non-toxic, and capable of inducing robust antitumor immune responses in animal models and human patients (2, 3). Talimogene laherparepvec (T-VEC), a genetically engineered OV, was recently approved for the treatment of melanoma, representing the primary oncolytic virus to be approved by the FDA as an anti cancer therapy.
Thanks to this triple mode of action (cell lysis, systemic anti-cancer immune reaction , local inflammation) and therefore the incontrovertible fact that OV-therapy are often combined with conventional tumor therapies (e.g. chemotherapy, immunotherapy), OVs are exciting and highly promising new anticancer agents. Especially genetically modified OVs, which overcome the restrictions of wild-type viruses, have shown great potential within the treatment of cancer. Efficacy has been shown for several OVs in clinical trials, in order that oncolytic virotherapy has become an accepted new strategy for the treatment of cancer.
High Impact List of Articles
-
Oncology Conference Series Announces the Date and Venue for Unique Conference Deliberated on Preventive Oncology
Ibrahim Mashaal -
Oncology Conference Series Announces the Date and Venue for Unique Conference Deliberated on Preventive Oncology
Ibrahim Mashaal -
9th European Congress on Breast Cancer, Women's Health and Therapeutics
Ibrahim Mashaal -
9th European Congress on Breast Cancer, Women's Health and Therapeutics
Ibrahim Mashaal -
Announcement of 15th Global Summit on Oncology and Cancer
Stefan Glueck -
Announcement of 15th Global Summit on Oncology and Cancer
Stefan Glueck -
13th International Conference on Cancer Stem Cells and Oncology Research
Dr. Burkhard Brandt -
13th International Conference on Cancer Stem Cells and Oncology Research
Dr. Burkhard Brandt -
World Congress on Preventive Oncology
Ibrahim Mashaal -
World Congress on Preventive Oncology
Ibrahim Mashaal -
Transgelin Protein Expression in Colorectal Cancer: A Clinicopathological Study.
Kota Amemiya, Motohiro Kojima, Akiko Nagatuma, Shingo Kawano, Makoto Takahashi, Hiromitu Komiyama, Kazuhiro Sakamoto, Atsushi Ochiai, Masaaki itoResearch Article: Journal of Clinical Oncology and Cancer Research
-
Transgelin Protein Expression in Colorectal Cancer: A Clinicopathological Study.
Kota Amemiya, Motohiro Kojima, Akiko Nagatuma, Shingo Kawano, Makoto Takahashi, Hiromitu Komiyama, Kazuhiro Sakamoto, Atsushi Ochiai, Masaaki itoResearch Article: Journal of Clinical Oncology and Cancer Research
-
Prostatic metastasis from Intrahepatic Cholangiocarcinoma.
Georgi Tosev*, Viktoria Schuetz, Joanne Nyarangi-Dix, Albrecht Stenzinger, Fabian Stoegbauer, Yakup Kulu, Jan P. Radtke, Dogu Teber, Martin Hatzinger, Christoph Springfeld, Bruno C. Koehler. and Markus HohenfellnerCase Report: Journal of Clinical Oncology and Cancer Research
-
Prostatic metastasis from Intrahepatic Cholangiocarcinoma.
Georgi Tosev*, Viktoria Schuetz, Joanne Nyarangi-Dix, Albrecht Stenzinger, Fabian Stoegbauer, Yakup Kulu, Jan P. Radtke, Dogu Teber, Martin Hatzinger, Christoph Springfeld, Bruno C. Koehler. and Markus HohenfellnerCase Report: Journal of Clinical Oncology and Cancer Research
Conference Proceedings
-
Trilateral Retinoblastoma: A rare case report
Sai Kumar Maley, Rahul Dev Singh, Uma Nagendra Vishnu, Chanakya Charan Tirumala, Siddartha Reddy Musali and Sandeep LakkarasuPosters & Accepted Abstracts: Journal of Pathology and Disease Biology
-
Trilateral Retinoblastoma: A rare case report
Sai Kumar Maley, Rahul Dev Singh, Uma Nagendra Vishnu, Chanakya Charan Tirumala, Siddartha Reddy Musali and Sandeep LakkarasuPosters & Accepted Abstracts: Journal of Pathology and Disease Biology
-
Recent advances in the molecular testing for treatment selection in lung cancer
Mulazim Hussain BukhariPosters & Accepted Abstracts: Journal of Pathology and Disease Biology
-
Recent advances in the molecular testing for treatment selection in lung cancer
Mulazim Hussain BukhariPosters & Accepted Abstracts: Journal of Pathology and Disease Biology
-
Immunohistochemical expression and microsatellite instability in endometrial carcinoma
Hala Naguib HosniPosters & Accepted Abstracts: Journal of Pathology and Disease Biology
-
Immunohistochemical expression and microsatellite instability in endometrial carcinoma
Hala Naguib HosniPosters & Accepted Abstracts: Journal of Pathology and Disease Biology
-
Intracranial falcine chondroma: A case report and review of literature
Ahmed A S Elhakeem and Abd Elhakeem EssaScientific Tracks Abstracts: Journal of Pathology and Disease Biology
-
Intracranial falcine chondroma: A case report and review of literature
Ahmed A S Elhakeem and Abd Elhakeem EssaScientific Tracks Abstracts: Journal of Pathology and Disease Biology
-
Dural Lymphoma
Muhammad ZulfiqarScientific Tracks Abstracts: Journal of Pathology and Disease Biology
-
Dural Lymphoma
Muhammad ZulfiqarScientific Tracks Abstracts: Journal of Pathology and Disease Biology
-
Inhibition of ERKs/RSK2/IκBα signaling axis by magnolin suppresses cancer cell invasion and migration
Sun-Mi Yoo, Cheol-Jung Lee, Sueng-Min Kim, Seon-Yeon Cho and Yong-Yeon ChoPosters & Accepted Abstracts: Journal of Clinical and Experimental Toxicology
-
Inhibition of ERKs/RSK2/IκBα signaling axis by magnolin suppresses cancer cell invasion and migration
Sun-Mi Yoo, Cheol-Jung Lee, Sueng-Min Kim, Seon-Yeon Cho and Yong-Yeon ChoPosters & Accepted Abstracts: Journal of Clinical and Experimental Toxicology